Treatment of Fungal Meningitis With Miconazole

Stanley C. Deresinski, Ralph B. Lilly, H. B. Levine, John N Galgiani, David A. Stevens

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Twelve patients with fungal meningitis (ten cases were due to Coccidioides immitis, two were from Cryptococcus neoformans) were treated with brief courses of intravenous (IV) miconazole. Eleven patients, including patients with severe, chronic disease, had been treated unsuccessfully with amphotericin B. Four patients also received miconazole injected directly into the CSF. The drug was well tolerated by any route, with mild reversible side effects. After IV administration the miconazole concentration in the CSF rarely exceeded the minimal inhibitory concentration (MIC) of the infecting organism. Intra-CSF administration of 20 mg generally produced levels above the MIC for 24 hours. Five of ten patients with coccidioidal meningitis responded clinically. Of these five, four received only IV miconazole; three relapsed after therapy was stopped. Miconazole appears promising as a treatment of fungal meningitis, but trials of longer duration might prevent relapse.

Original languageEnglish (US)
Pages (from-to)1180-1185
Number of pages6
JournalArchives of Internal Medicine
Volume137
Issue number9
DOIs
StatePublished - 1977
Externally publishedYes

Fingerprint

Fungal Meningitis
Miconazole
Coccidioides
Therapeutics
Cryptococcus neoformans
Amphotericin B
Meningitis
Intravenous Administration
Chronic Disease
Recurrence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Deresinski, S. C., Lilly, R. B., Levine, H. B., Galgiani, J. N., & Stevens, D. A. (1977). Treatment of Fungal Meningitis With Miconazole. Archives of Internal Medicine, 137(9), 1180-1185. https://doi.org/10.1001/archinte.1977.03630210054018

Treatment of Fungal Meningitis With Miconazole. / Deresinski, Stanley C.; Lilly, Ralph B.; Levine, H. B.; Galgiani, John N; Stevens, David A.

In: Archives of Internal Medicine, Vol. 137, No. 9, 1977, p. 1180-1185.

Research output: Contribution to journalArticle

Deresinski, SC, Lilly, RB, Levine, HB, Galgiani, JN & Stevens, DA 1977, 'Treatment of Fungal Meningitis With Miconazole', Archives of Internal Medicine, vol. 137, no. 9, pp. 1180-1185. https://doi.org/10.1001/archinte.1977.03630210054018
Deresinski, Stanley C. ; Lilly, Ralph B. ; Levine, H. B. ; Galgiani, John N ; Stevens, David A. / Treatment of Fungal Meningitis With Miconazole. In: Archives of Internal Medicine. 1977 ; Vol. 137, No. 9. pp. 1180-1185.
@article{f6e5635c9a0d4213a2eadc5f4d58bcdb,
title = "Treatment of Fungal Meningitis With Miconazole",
abstract = "Twelve patients with fungal meningitis (ten cases were due to Coccidioides immitis, two were from Cryptococcus neoformans) were treated with brief courses of intravenous (IV) miconazole. Eleven patients, including patients with severe, chronic disease, had been treated unsuccessfully with amphotericin B. Four patients also received miconazole injected directly into the CSF. The drug was well tolerated by any route, with mild reversible side effects. After IV administration the miconazole concentration in the CSF rarely exceeded the minimal inhibitory concentration (MIC) of the infecting organism. Intra-CSF administration of 20 mg generally produced levels above the MIC for 24 hours. Five of ten patients with coccidioidal meningitis responded clinically. Of these five, four received only IV miconazole; three relapsed after therapy was stopped. Miconazole appears promising as a treatment of fungal meningitis, but trials of longer duration might prevent relapse.",
author = "Deresinski, {Stanley C.} and Lilly, {Ralph B.} and Levine, {H. B.} and Galgiani, {John N} and Stevens, {David A.}",
year = "1977",
doi = "10.1001/archinte.1977.03630210054018",
language = "English (US)",
volume = "137",
pages = "1180--1185",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Treatment of Fungal Meningitis With Miconazole

AU - Deresinski, Stanley C.

AU - Lilly, Ralph B.

AU - Levine, H. B.

AU - Galgiani, John N

AU - Stevens, David A.

PY - 1977

Y1 - 1977

N2 - Twelve patients with fungal meningitis (ten cases were due to Coccidioides immitis, two were from Cryptococcus neoformans) were treated with brief courses of intravenous (IV) miconazole. Eleven patients, including patients with severe, chronic disease, had been treated unsuccessfully with amphotericin B. Four patients also received miconazole injected directly into the CSF. The drug was well tolerated by any route, with mild reversible side effects. After IV administration the miconazole concentration in the CSF rarely exceeded the minimal inhibitory concentration (MIC) of the infecting organism. Intra-CSF administration of 20 mg generally produced levels above the MIC for 24 hours. Five of ten patients with coccidioidal meningitis responded clinically. Of these five, four received only IV miconazole; three relapsed after therapy was stopped. Miconazole appears promising as a treatment of fungal meningitis, but trials of longer duration might prevent relapse.

AB - Twelve patients with fungal meningitis (ten cases were due to Coccidioides immitis, two were from Cryptococcus neoformans) were treated with brief courses of intravenous (IV) miconazole. Eleven patients, including patients with severe, chronic disease, had been treated unsuccessfully with amphotericin B. Four patients also received miconazole injected directly into the CSF. The drug was well tolerated by any route, with mild reversible side effects. After IV administration the miconazole concentration in the CSF rarely exceeded the minimal inhibitory concentration (MIC) of the infecting organism. Intra-CSF administration of 20 mg generally produced levels above the MIC for 24 hours. Five of ten patients with coccidioidal meningitis responded clinically. Of these five, four received only IV miconazole; three relapsed after therapy was stopped. Miconazole appears promising as a treatment of fungal meningitis, but trials of longer duration might prevent relapse.

UR - http://www.scopus.com/inward/record.url?scp=84942951410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942951410&partnerID=8YFLogxK

U2 - 10.1001/archinte.1977.03630210054018

DO - 10.1001/archinte.1977.03630210054018

M3 - Article

VL - 137

SP - 1180

EP - 1185

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 9

ER -